Literature DB >> 11115067

Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA.

L Peruzzi1, A Amore, P Cirina, L Trusolino, G Basso, E Ricotti, S N Emancipator, P C Marchisio, R Coppo.   

Abstract

BACKGROUND: Signal transduction by mesangial cell (MC) integrins regulates cell growth and survival, extracellular matrix production, and organization. The aim of the study was to investigate human MC integrin modulation by differently glycosylated IgA and macromolecular IgA, which are thought to play a pathogenetic role in IgA nephropathy (IgAN).
METHODS: MCs were incubated with purified human polymeric IgA, heat-aggregated IgA, IgA glycoforms generated by enzymatic hydrolysis of saccharide residues and serum fractions from IgAN patients, and controls isolated by lectin affinity and containing IgA with peculiar glycan patterns. Integrins were quantitated by flow cytometry.
RESULTS: Cultured MCs highly expressed alphavbeta3 and some alpha3beta1; alphavbeta3 was up-regulated by matrix components (P < 0.02). In vitro desialylated and degalactosylated polymeric human IgA enhanced alphavbeta3 expression on cultured MCs (P < 0.001). Serum IgA glycoforms isolated from IgAN patients with high exposure of internal sugars, GalNAc, Neu5Ac2,6GalNAc, and Man enhanced alphav expression on cultured MCs more than healthy controls. CONCLUSIONS.: These data support the hypothesis that IgA glycation plays a role in modulating the cell-matrix interaction, and that this mechanism can be operating in IgAN.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115067     DOI: 10.1046/j.1523-1755.2000.00417.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

Review 2.  IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease.

Authors:  Jing Xue; Li-Ping Zhu; Qiang Wei
Journal:  Glycoconj J       Date:  2013-06-20       Impact factor: 2.916

3.  C4d deposits in IgA nephropathy: where does complement activation come from?

Authors:  Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2017-02-14       Impact factor: 3.714

Review 4.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

Review 5.  Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.

Authors:  Ichiei Narita; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2008-04-12       Impact factor: 2.801

6.  Suppression of adiponectin by aberrantly glycosylated IgA1 in glomerular mesangial cells in vitro and in vivo.

Authors:  Tatsuyuki Inoue; Hitoshi Sugiyama; Masashi Kitagawa; Keiichi Takiue; Hiroshi Morinaga; Ayu Ogawa; Yoko Kikumoto; Shinji Kitamura; Yohei Maeshima; Hirofumi Makino
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

7.  The Feasibility of Targeted Magnetic Iron Oxide Nanoagent for Noninvasive IgA Nephropathy Diagnosis.

Authors:  Yaoyao Wu; Qiang Huang; Junli Wang; Yuhua Dai; Ming Xiao; Yangyang Li; Hongbo Zhang; Wenbo Xiao
Journal:  Front Bioeng Biotechnol       Date:  2021-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.